Show simple item record

dc.contributor.advisorMahender Singh.en_US
dc.contributor.authorRimling, Eric C. (Eric Christopher)en_US
dc.contributor.authorSeoh, Wontae Thomasen_US
dc.contributor.otherMassachusetts Institute of Technology. Engineering Systems Division.en_US
dc.date.accessioned2010-04-07T13:39:01Z
dc.date.available2010-04-07T13:39:01Z
dc.date.copyright2009en_US
dc.date.issued2009en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/53543
dc.descriptionThesis (M. Eng. in Logistics)--Massachusetts Institute of Technology, Engineering Systems Division, 2009.en_US
dc.descriptionIncludes bibliographical references (leaves 77-78).en_US
dc.description.abstractThe pharmaceutical industry creates products which often have more than one supply chain channel, defined as a route through the supply chain network from sourcing to the end market. Each channel's specific cost characteristics are important to the pharmaceutical industry's ability to maintain positive profit margins while meeting high customer service requirements. Determining the optimal supply chain channel involves the analysis of fuel costs, logistics, taxes, wage differences, and many more. Additionally, variables such as time and risk significantly impact the total cost of a supply chain channel, but are extremely difficult to quantify. In this research, we identify the relevant channel costs and variables for the supply chain of a large pharmaceutical corporation. After identification, our study categorizes each cost based on level of measurability and causes of variability to develop a framework identifying the most relevant costs by four product types. We then analyze market forces that affect costs over a product's lifecycle. Finally, we develop an operational model for using the framework to compare costs across multiple supply chain channels and time horizons.en_US
dc.description.statementofresponsibilityby Eric C. Rimling and Wontae Thomas Seoh.en_US
dc.format.extent90 leavesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectEngineering Systems Division.en_US
dc.titleAnalysis of global channel costs for the pharmaceutical industryen_US
dc.typeThesisen_US
dc.description.degreeM.Eng.in Logisticsen_US
dc.contributor.departmentMassachusetts Institute of Technology. Engineering Systems Division
dc.identifier.oclc497151365en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record